Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003630:Daunorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015255:Idarubicin; D007970:Leukopenia / Q000139:chemically induced; D009362:Neoplasm Metastasis
D000903:Antibiotics, Antineoplastic; D015255:Idarubicin; D003630:Daunorubicin